Summit Trail Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.63M Buy
109,719
+10,048
+10% +$246K 0.04% 369
2025
Q4
$2.26M Buy
99,671
+16,129
+19% +$351K 0.04% 339
2025
Q3
$1.68M Buy
83,542
+39,407
+89% +$660K 0.02% 538
2025
Q2
$630K Buy
+44,135
New +$516K 0.01% 643
2025
Q1
Sell
-16,428
Closed -$199K 435
2024
Q4
$199K Buy
+16,428
New +$215K 0.01% 359

Other funds holding ELAN

Summit Trail Advisors's ELAN Position: Q1 2026 in Review

Summit Trail Advisors increased its Elanco Animal Health (ELAN) stake by 10% in Q1 2026, buying an estimated $246K and bringing the position to 109,719 shares worth $2.63M. The position accounts for 0.04% of the portfolio, ranked #369.

Summit Trail Advisors first reported a position in ELAN in Q4 2024 and has held it in 5 quarters since. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Summit Trail Advisors held 109,719 shares of Elanco Animal Health worth $2.63M as of Q1 2026.
  • Summit Trail Advisors bought 10,048 Elanco Animal Health shares in Q1 2026, an estimated $246K.
  • Elanco Animal Health made up 0.04% of Summit Trail Advisors's portfolio in Q1 2026, its #369 holding.
  • Summit Trail Advisors first reported a position in Elanco Animal Health in Q4 2024 and has held it in 5 quarters since.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.